NCT00419328 2022-07-21
A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors
AGC Biologics S.p.A.
Phase 1 Completed
Clinical Trials
1 trialsPhase 1 × Advanced Solid Tumors × tumor necrosis factor-alpha, CNGRC fusion protein, human × Clear all